FDA Inspection
Illume FertilityIllume Fertility – FDA Inspection, Feb 23, 2021
Record Details
This FDA Inspection record concerns Illume Fertility, with an inspection on February 23, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Illume Fertility
- Inspection Date
- February 23, 2021
- Product Type
- Biologics
View Company Profile
ID · c917ed2f-1621-4fef-a4f0-f1ee05352e85
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1136119
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Illume Fertility
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2026 | Not classified | New England District Office | Human Cellular, Tissue, and Gene Therapies |
| June 30, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 3, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 6, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 13, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Illume Fertility
- FDA Inspection 1316476 - 2026-05-08
- FDA Inspection 1209647 - 2023-06-30
- FDA Inspection 1049283 - 2018-04-03
- FDA Inspection 964581 - 2016-04-06
- FDA Inspection 859492 - 2013-12-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.